Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | C5AR1 | P21730 | 2/20 | 0.66 |
| ▸ | CD47 | Q08722 | 1/20 | 0.58 |
| ▸ | IL23R | Q5VWK5 | 6/20 | 0.58 |
| ▸ | GLP1R | P43220 | 8/20 | 0.57 |
| ▸ | GCGR | P47871 | 1/20 | 0.56 |
| ▸ | GHSR | Q92847 | 2/20 | 0.54 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.54 |
| ▸ | TUBB | P07437 | 1/20 | 0.54 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.54 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.54 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.54 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.54 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.54 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.54 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.54 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.54 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.54 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.54 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.54 |
| ▸ | TUBB2B | Q9BVA1 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30451312 | 0.96 | C5AR1 (0.70) | C5AR1IL23RGLP1RGCGR | |
| SCHEMBL29884974 | 0.93 | C5AR1 (0.58) | C5AR1CD47IL23RGLP1RGCGR | |
| SCHEMBL29461998 | 0.93 | C5AR1 (0.58) | C5AR1CD47IL23RGLP1RGCGR | |
| SCHEMBL29540499 | 0.93 | C5AR1 (0.58) | C5AR1CD47IL23RGLP1RGCGR | |
| SCHEMBL29641153 | 0.93 | C5AR1 (0.58) | C5AR1CD47IL23RGLP1RGCGR | |
| SCHEMBL29936674 | 0.92 | C5AR1 (0.59) | C5AR1IL23RGLP1RGCGRGHSR | |
| SCHEMBL30130535 | 0.92 | C5AR1 (0.61) | C5AR1CD47IL23RGLP1RGCGR | |
| SCHEMBL30130567 | 0.92 | C5AR1 (0.61) | C5AR1CD47IL23RGLP1RGCGR | |
| SCHEMBL29641022 | 0.91 | IL23R (0.58) | C5AR1IL23RGLP1RGHSRTUBB4A | |
| SCHEMBL31454699 | 0.91 | C5AR1 (0.60) | C5AR1CD47IL23RGLP1RGCGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250276116-A1 | METHODS OF MITIGATING MYOCARDIAL DAMAGE DUE TO EXTRACORPOREAL MEMBRANE OXYGENATION | TUFTS MEDICAL CENTER, INC. | 2025-09-04 | — | — | US | disclosed |
| US-20230346874-A1 | METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OPHTHALMIC CONDITIONS | STEALTH BIOTHERAPEUTICS INC. (US) | 2023-11-02 | — | — | US | disclosed |
| US-11612633-B2 | Methods and compositions for preventing or treating ophthalmic conditions | STEALTH BIOTHERAPEUTICS INC. (US) | 2023-03-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230346874-A1 | METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OPHTHALMIC CONDITIONS | CRYAA, CRYAB, IAPP | C5AR1 264/4885CD47 1832/4885IL23R 3422/4885 |
| US-11612633-B2 | Methods and compositions for preventing or treating ophthalmic conditions | CRYAA, CRYAB, IAPP | C5AR1 264/4885CD47 1832/4885IL23R 3422/4885 |
| US-20250276116-A1 | METHODS OF MITIGATING MYOCARDIAL DAMAGE DUE TO EXTRACORPOREAL MEMBRANE OXYGENATION | TNNI3, TNNT2, MB | C5AR1 576/4885CD47 2195/4885IL23R 4785/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.